Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells

International Journal of Cancer

Volumn 92, Issue 4, 2001, Pages 545-550

  Mentlein, Rolf ^a   Eichler, Olaf ^a   Forstreuter, Frauke ^a   Held Feindt, Janka ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Angiogenesis; Glioma; Growth factor; Somatostatin; Vascular endothelial growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; MESSENGER RNA; OCTREOTIDE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER STAGING; CELL HYPOXIA; CELL STIMULATION; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ANOXIA; ANTINEOPLASTIC AGENTS, HORMONAL; BENZIMIDAZOLES; BLOTTING, NORTHERN; BRAIN NEOPLASMS; CELLS, CULTURED; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIOMA; HORMONES; HUMANS; INDOLES; LYMPHOKINES; OCTREOTIDE; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOMATOSTATIN; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035874075     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1223     Document Type: Article

References (30)

1. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
2. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
3. Gliomas
4. Tumor cell invasion and angiogenesis in the central nervous system
5. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
6. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
7. VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS
8. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGFBB, and bFGF
9. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1
10. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
11. Vascular endothelial growth factor and its receptors
12. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor
13. Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells
14. 111Indium (DTPA-octreotide) scintigraphy in patients with cerebral gliomas
15. Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas
16. Molecular analysis of the somatostatin receptor subtype 2 (SST2) in human glioma cells
17. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2
18. Receptor subtypes and effects of the neuropeptide somatostatin in microglial cells
19. Reverse transcription-polymerase chain reaction products of alternatively spliced mRNAs form heteroduplexes and heteroduplex complexes
20. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells
21. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells
22. Receptors and effects of the inhibitory neuropeptide somatostatin in glial derivatives
23. Degradation of the neuropeptide somatostatin by cultivated neuronal and glial cells
24. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
25. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through tyrosine phosphatase SHP-1
26. Influence of somatostatin receptor sst2 on growth factor signal cascades in human glioma cells
27. Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995)
28. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
29. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo
30. 3-octreotide (DOTATOC): A pilot study in human gliomas